The insulin glargine dilemma: an opportunity for the diabetes community?
Stumvoll
M
M
Department of Medicine, University of Leipzig, Germany. michael.stumvoll@medizin.uni-leipzig.de
Nawroth
P P
PP
D003920:Diabetes Mellitus / Q000188:drug therapy*; D004345:Drug Industry / Q000458:organization & administration* / Q000592:standards; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D033183:Interdisciplinary Communication; D011362:Professional Corporations / Q000458:organization & administration* / Q000592:standards; D015980:Public Health Practice
D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine
Diabetologia. 2009 Sep;52(9):1745-54
19588120
Diabetologia. 2009 Sep;52(9):1971-3
19609501
Diabetes. 2000 Jun;49(6):999-1005
10866053
Diabetologia. 2009 Sep;52(9):1755-65
19603149
Diabetologia. 2009 Sep;52(9):1778-88
19526210
Diabetes Care. 2008 Jun;31(6):1105-11
18316392
Am Heart J. 2008 Jan;155(1):26-32, 32.e1-6
18082485
Diabetologia. 2009 Sep;52(9):1732-44
19565214
Diabetologia. 2009 Sep;52(9):1766-77
19572116
Diabetologia. 2009 Sep;52(9):1699-708
19597799